Loading
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Previous close
$5.88
−$0.18 · -2.97%
After-hours
$5.85
−$0.03 · -0.51%
Sep 14, 7:46 PM ET
Regular session · ET · Market data may be delayed.
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Day range
Current $5.88
52-week range
Current $5.88
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
68
Undervalued
Sentiment
69
Bullish
Risk
43
Elevated Risk
Momentum
40
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Day range
Current $5.88
52-week range
Current $5.88
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.24B USD | 3.26B USD | 3.2B USD | 2.97B USD | 2.45B USD |
| Cost of goods sold | 2.68B USD | 2.58B USD | 2.52B USD | 2.55B USD | 2.01B USD |
| Gross profit | 568.56M USD | 681.09M USD | 681.77M USD | 417.43M USD | 445.61M USD |
| Selling, general, and administrative | 382.29M USD | 359.24M USD | 190.09M USD | 162.13M USD | 167.51M USD |
| Operating expenses | 382.29M USD | 417.36M USD | 1.28B USD | 227.02M USD | 220.01M USD |
| Interest expense | 105.75M USD | 126.67M USD | 130.3M USD | 109.41M USD | 95.2M USD |
| Depreciation and amortization | 413.04M USD | 365.33M USD | 420.59M USD | 423.44M USD | 258.05M USD |
| Operating income | 186.27M USD | 263.73M USD | −598.4M USD | 190.41M USD | 225.61M USD |
| Net income | −70.79M USD | 90.42M USD | −678.9M USD | 69.32M USD | 156.18M USD |
Company facts updated Sep 15, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$10.00
70.07% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI37.39M0.00%2.3T USD0.03%$374.68-0.43%
Vanguard Morningstar Small-Cap ETFVB27.1M0.01%183.4B USD0.03%$292.37-0.37%
Vanguard Morningstar Small-Cap Value ETFVBR17.17M0.03%68.3B USD0.05%$241.66-0.18%
iShares Russell 2000 ETFIWM16.34M0.02%78.38B USD0.19%$287.91-0.34%
Vanguard Extended Market ETFVXF13.38M0.01%93.7B USD0.05%$236.92-0.35%
Vanguard Russell 2000 ETFVTWO6.23M0.03%17.4B USD0.06%$116.37-0.33%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM5.98M0.04%16.32B USD0.03%$54.94-0.67%
Dimensional - US Targeted Value ETFDFAT5.94M0.04%14.43B USD0.28%$70.17-0.36%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMDimensional - US Targeted Value ETFDFATAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
